Prospective study of concomitant stereotaxic reirradiation and mitomycin with cetuximab for recurrent head and neck cancer.

被引：0
|
作者：
Nathalie, Lemoine
Lefebvre, Gautier
Tresch, Emmanuelle
Degardin, Marian
Maillard, Sophie
Coche-Dequant, Bernard
Singier, Stephane
Mailliez, Audrey
Marliot, Guillaume
Sakji, Ilyes
Amela, Eric
Kotecki, Nuria
Penel, Nicolas
El Bedoui, Sophie
Julieron, Morbize
Lartigau, Eric
机构：
[1] Hop La Louviere, Lille, France
[2] Ctr Oscar Lambret, F-59020 Lille, France
[3] Ctr Oscar Lambret, Wattignies, France
[4] Oscar Lambret Comprehens Canc Ctr, Lille, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
10.1200/jco.2015.33.15_suppl.e17024
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e17024
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Cetuximab in metastatic or recurrent head and neck cancer: the EXTREME trial
    Rivera, Fernando
    Garcia-Castano, Almudena
    Vega, Noelia
    Eugenia Vega-Villegas, M.
    Gutierrez-Sanz, Lourdes
    EXPERT REVIEW OF ANTICANCER THERAPY, 2009, 9 (10) : 1421 - 1428
  • [42] A prospective study on postoperative reirradiation (report) for recurrent and second primary head and neck squamous cell carcinoma
    Kasperts, N
    Doornaert, P
    Slotman, BJ
    Leemans, CR
    Langendijk, JA
    RADIOTHERAPY AND ONCOLOGY, 2004, 73 : S314 - S315
  • [43] Reirradiation in recurrence of head and neck cancer
    Loessl, K.
    Beer, K. T.
    Aebersold, D.
    Greiner, R. H.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2006, 182 : 174 - 174
  • [44] Efficacy of reirradiation in head and neck cancer
    Diaz Gomez, L.
    Gonzalez Calvo, E.
    Gutierrez Bayard, L.
    Villanego Beltran, I.
    Munive Alvarez, E.
    Diaz Diaz, V.
    De Ingunza Baron, L.
    Salas Buzon, M. C.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S764 - S764
  • [45] mTOR inhibition can overcome cetuximab resistance in head and neck cancer.
    Wang, Zhiyong
    Martin, Daniel
    Patel, Vyomesh
    Molinolo, Alfredo Alberto
    Chen, Qianming
    Gutkind, J. Silvio
    CANCER RESEARCH, 2013, 73 (08)
  • [46] Reirradiation in head and neck recurrent cancer or second primary. Our experience
    Gutierrez Bayard, Lucia
    Rodriguez Sanchez, Raquel
    Munoz Higueras, Cristina
    ORAL ONCOLOGY, 2021, 118
  • [47] Reirradiation: a potentially curative approach to locally or regionally recurrent head and neck cancer
    Garofalo, MC
    Haraf, DJ
    CURRENT OPINION IN ONCOLOGY, 2002, 14 (03) : 330 - 333
  • [48] Efficacy of PD-1 inhibition in recurrent Head and Neck cancer. A national prospective cohort study.
    Soby, S.
    Gothelf, A.
    Gyldenkerne, N.
    Bentzen, J.
    Nowicka-Matus, K.
    Tramm, T.
    Eriksen, J. G.
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S840 - S840
  • [49] Reirradiation with concomitant chemotherapy in platinum refractory head and neck cancers
    Martin, L.
    Piot, G.
    Damour, M.
    Moran, A.
    RADIOTHERAPY AND ONCOLOGY, 2007, 82 : S74 - S74
  • [50] ACUTE TOXICITY IN HEAD AND NECK CANCER PATIENTS TREATED WITH CONCOMITANT RADIOTHERAPY AND CETUXIMAB
    Caparrotti, F.
    Schick, U.
    Mach, N.
    Dulguerov, P.
    Miralbell, R.
    Betz, M.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2010, 186 (12) : 732 - 732
12345